HCID 67139624, compound → HCID 10194917, compound
Reaction equation
[CH3:1][S:2]([C:5]1[CH:40]=[CH:39][C:8]([CH2:9][O:10][C:11](=[O:38])[C:12]2[CH:17]=[CH:16][C:15]([CH2:18][N:19]3[CH2:23][C:22](=[O:24])[N:21](CC4C=CC(OC)=CC=4OC)[S:20]3(=[O:37])=[O:36])=[CH:14][CH:13]=2)=[CH:7][CH:6]=1)(=[O:4])=[O:3]>C(Cl)Cl>[CH3:1][S:2]([C:5]1[CH:6]=[CH:7][C:8]([CH2:9][O:10][C:11](=[O:38])[C:12]2[CH:13]=[CH:14][C:15]([CH2:18][N:19]3[CH2:23][C:22](=[O:24])[NH:21][S:20]3(=[O:36])=[O:37])=[CH:16][CH:17]=2)=[CH:39][CH:40]=1)(=[O:4])=[O:3]Participants
3
Reactant 1
Product 1
Reagents, catalysts & solvents 1
Procedure
90 mg (150 μmol) of the title D compound, 4-[5-(2,4-dimethoxy-benzyl)-1,1,4-trioxo-1,2,5-thiadiazolidin-2-ylmethyl]-benzoic acid 4-methanesulfonyl-benzyl ester are stirred in 4 mL of 1:1—TFA:CH2Cl2 for 50 min. The solvent is removed and the residue triturated with 4 mL of 1:1—MeCN:H2O. This mixture is filtered through a 0.2μ disk and the solvent is removed. The resulting material is purified by LC/MS and afforded 4-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-ylmethyl)-benzoic acid 4-methanesulfonyl-benzyl ester: 1H-NMR (DMSO-d6) δ 3.22 (3H, s), 3.71 (2H, s), 4.27 (2H, s), 5.48 (2H, s), 7.54 (2H, d, J=8.1), 7.74 (2H, d, J=8.1), 7.96 (2H, d, J=8.5), 8.01 (2H, J=8.5); [M−1]−=437.
Workup
- customThe solvent is removed
- customthe residue triturated with 4 mL of 1
- filtrationThis mixture is filtered through a 0.2μ disk
- customthe solvent is removed
- customThe resulting material is purified by LC/MS
Sources & evidence
- ORD record
- ord-aa90ed190bd4411faf8ed4c35532749d
- Source dataset
- uspto-grants-2007_11
- Patent number
- US07291635B2
Reaction notes
Loading…